peptide elongation factor 2 has been researched along with Carcinoma, Hepatocellular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Tan, HY; Tsao, SW; Wang, N; Zhang, Z | 1 |
1 other study(ies) available for peptide elongation factor 2 and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Suppression of vascular endothelial growth factor via inactivation of eukaryotic elongation factor 2 by alkaloids in Coptidis rhizome in hepatocellular carcinoma.
Topics: Alkaloids; Angiogenesis Inhibitors; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Coptis chinensis; Drugs, Chinese Herbal; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Nude; Neovascularization, Pathologic; Peptide Elongation Factor 2; Real-Time Polymerase Chain Reaction; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2014 |